Перейти к содержанию

Resmed Inc (RMD) stock: revenue, earnings & dividend

Resmed Inc (RMD, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener RMD · NYSE Medizintechnik & Messgeräte US-CA

Key figures

Fiscal year
2025
Revenue
5.15 bn $
Revenue growth
9.8 %
Revenue growth 5y (p.a.)
11.7 %
Net income
1.4 bn $
Net margin
27.2 %
Operating margin
32.8 %
Earnings per share (diluted)
9.51 $
Dividend per share
2.12 $
Payout ratio
22.3 %
Consecutive dividend years
13 years
Consecutive dividend raises
4 years
Dividend growth 5y (p.a.)
6.3 %
Total assets
8.5 bn $
Equity
6.32 bn $
Equity ratio
74.3 %
Return on equity
22.2 %
Cash
1.42 bn $
Operating cash flow
1.75 bn $
Free cash flow
1.66 bn $
Shares outstanding
140,657,071

History

Revenue by fiscal year

2016 1.84 bn $
2017 2.07 bn $
2018 2.34 bn $
2019 2.61 bn $
2020 2.96 bn $
2021 3.2 bn $
2022 3.58 bn $
2023 4.22 bn $
2024 4.69 bn $
2025 5.15 bn $

Net income by fiscal year

2016 352 m $
2017 342 m $
2018 316 m $
2019 405 m $
2020 622 m $
2021 475 m $
2022 779 m $
2023 898 m $
2024 1.02 bn $
2025 1.4 bn $

Dividend per share

2016 1.20 $
2017 1.32 $
2018 1.40 $
2019 1.48 $
2020 1.56 $
2021 1.56 $
2022 1.68 $
2023 1.76 $
2024 1.92 $
2025 2.12 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20255.15 bn $1.4 bn $9.51 $2.12 $1.75 bn $
20244.69 bn $1.02 bn $6.92 $1.92 $1.4 bn $
20234.22 bn $898 m $6.09 $1.76 $693 m $
20223.58 bn $779 m $5.30 $1.68 $351 m $
20213.2 bn $475 m $3.24 $1.56 $737 m $
20202.96 bn $622 m $4.27 $1.56 $802 m $
20192.61 bn $405 m $2.80 $1.48 $459 m $
20182.34 bn $316 m $2.19 $1.40 $505 m $
20172.07 bn $342 m $2.40 $1.32 $414 m $
20161.84 bn $352 m $2.49 $1.20 $548 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)